Ottobock stock: WIRobotics expands North American distribution
Published on 11/18/2026 at 18:03 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSNorth American rollout takes shape
- WIRobotics will supply WIM S while Ottobock handles distribution in the United States and Canada.
- Sales begin in the United States through online platforms and selected orthotic and prosthetic clinics.
- Further US trial locations and Canadian sales depend on customer feedback.
WIRobotics announced on Wednesday, November 18, that its US subsidiary had signed a distribution and sales agreement with Otto Bock HealthCare LP on October 15. Ottobock will distribute the WIM S wearable mobility robot in the United States and Canada, with the US launch coming first, according to PR Newswire.
WIRobotics USA will supply the device, while consumers will be able to purchase it through Ottobock's online platform and WIRobotics USA's online store. Selected US orthotic and prosthetic clinics will also offer opportunities to try WIM S.
US launch leads the rollout
The companies plan to use customer feedback to consider more trial locations in the United States and to extend sales to Canada. Their cooperation also covers market development, brand building, product training and after-sales service, with WIRobotics USA supporting local training and service operations.
The announcement gives Ottobock a new distribution role in wearable mobility technology, but the commercial terms were not disclosed. WIM has surpassed 4,000 cumulative units in its third year of commercialization, with sales extending beyond South Korea to Europe, China and Japan.
Stock trades lower than earlier
Ottobock stock traded at 37.78 euros on Lang & Schwarz at 17:58 CET on Wednesday, November 18. That was 2.38 percent below the 38.70 euros quoted in the November 18 report at 11:37 CET, separating the intraday move from the company's new distribution announcement.
Ottobock company snapshot
- Company: Ottobock SE & Co. KGaA
- ISIN: DE000BCK2223
- Quoted price: 37.78 euros
- Trading venue: Lang & Schwarz
- Quote time: 17:58 CET, Wednesday, November 18, 2026
European medical-technology shares remain in focus as investors weigh new product channels against the pace of commercial adoption. Current market reports provide the broader market context.
